Service d'Urologie, Hôpital Pitié-Salpêtrière
Paris, France
NCT Number: NCT04008108
The management of urinary incontinence seems to improve daily activities and the practice of physical activity, according to the literature. Unfortunately, all of these studies are based on self-questionnaires with the disadvantages of self-evaluation, more subjective.
For several years activity sensors have been used in the medical field (rheumatology, cardiology, diabetology, etc.). They allowed the evaluation of physical activity in real life situations, whether to evaluate the degree of severity of a pathology or the impact of a new treatment on the resumption of activities.
Activity sensors are devices that transform body motion into digital measurements. They provide detailed information on the frequency, duration, intensity and type of movement to determine, for example, the number of steps taken, the distance traveled, calories burned and the quality of sleep.
It is hypothesized that urinary incontinence treatment can increase physical activity and so improve the quality of life of patients, that can be measure by activity sensors.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, France
The management of urinary incontinence seems to improve daily activities and the practice of physical activity, according to the literature. Unfortunately, all of these studies are based on self-questionnaires with the disadvantages of self-evaluation, more subjective.
The artificial urinary sphincter (AUS) implantation is an effective treatment on stress urinary incontinence in men and women. Currently the PadTest/24 hours is the reference for his evaluation.
For several years activity sensors have been used in the medical field (rheumatology, cardiology, diabetology, etc.). They allowed the evaluation of physical activity in real life situations, whether to evaluate the degree of severity of a pathology or the impact of a new treatment on the resumption of activities.
Activity sensors are devices that transform body motion into digital measurements. They provide detailed information on the frequency, duration, intensity and type of movement to determine, for example, the number of steps taken, the distance traveled, calories burned and the quality of sleep.
It is hypothesized that urinary incontinence treatment can increase physical activity and so improve the quality of life of patients, that can be measure by activity sensors.
The research is a monocentric, prospective study.
The Primary objective of this study is to evaluate the variation of physical activity measured by the number of steps per day, before AUS implantation and 3 months after the activation of the sphincter.
For that, the primary outcome measure is the number of steps per day measured 24h/24 for 7 consecutive days by activity sensor, before AUS implantation and 3 months after activation of the sphincter.
All adult patients (men and women) with a surgical indication for urinary incontinence treatment by AUS in the urology department of Pitié-Salpêtrière hospital will be screened for eligibility.
Four visits will be programed as standard of care :
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Activity sensor worn on the wrist during 7 days, 24h/24 to evaluate physical activity of patient (measured by the number of step per day) before and after Artificial Urinary Sphincter Implantation.
Time frame: Through the study completion, an average of 8 months
Number of steps per day measured 24h/24 for 7 consecutive days by the activity sensor, at 3 months after activation of the AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Time frame: Through the study completion, an average of 6 months
Number of steps per day measured 24h/24 for 7 consecutive days by the activity sensor, at 1 month after activation of the AUS.
1 month after activation of the AUS is corresponding to 24 weeks from the inclusion (6 months).
Time frame: Through the study completion, an average of 8 months
Heart rate measured by the activity sensor preoperatively and at 1 month and 3 months after activation of the AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Time frame: Through the study completion, an average of 8 months
Sedentary and activity percentage a day measured by the activity sensor preoperatively and at 1 month and 3 months after activation of the AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Time frame: Through the study completion, an average of 8 months
I-QOL is a self-report Quality of Life measure specific to urinary problems. The I-QOL is commonly used and consists of 22 items, all of which use a five-point ordinal response scale in which 1 = extremely, 2 = quite a bit, 3 = moderately, 4 = a little, and 5 = not at all.
I-QOL scores are transformed to a 0-100 scale for easy interpretability. Higher scores indicate better quality of life.
Scale score = ((The sum of the items - lowest possible score) / Possible raw score range ) x 100.
Questionnaire I-QoL fulfilled before implantation and 3 months after activation of AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Time frame: Through the study completion, an average of 8 months
IPAQ is a 8 items questionnaire that assess 3 types of activity (walking, moderate-intensity activities and vigorous-intensity activities) in the following domains: leisure time, domestic/gardening, work-related, transport-related. It provide separate scores on each type of activity. Computation of the total score requires summation of the duration (in minutes) and frequency (days) of each type of activity. A Metabolic Equivalent Task (MET) is a multiple of the estimated resting energy expenditure.
Walking MET-minutes/week=3.3*walking minutes*walking days Moderate MET-minutes/week=4.0*moderate-intensity activity minutes*moderate days Vigorous MET-minutes/week=8.0*vigorous-intensity activity minutes*vigorous-intensity days Total =sum of Walking+Moderate+Vigorous METminutes/week scores.
Questionnaire IPAQ fulfilled before implantation and 3 months after activation of AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Time frame: Through the study completion, an average of 8 months
PAD-test / 24h performed at home preoperatively and 3 months after activation of AUS.
3 months after activation of the AUS is corresponding to 32 weeks from the inclusion (8 months).
Assistance Publique - Hôpitaux de Paris
Other
A Pilot Study to Evaluate the Variation of Physical Activity, Measured by the Number of Steps Per Day, After Artificial Urinary Sphincter Implantation
Acronym: AP-SU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03325543
Behavior, Female Urogenital Diseases
São Paulo, Brazil
View Trial DetailsNCT03166150
Atrophy, Behavior
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06268782
Behavior, Female Urogenital Diseases
Turku, Finland
View Trial DetailsNCT04037280
Behavior, Female Urogenital Diseases
Rozzano, Milan, Italy
View Trial Details